Global and Japan Molecular Influenza Diagnostic Market Size, Status and Forecast 2024-2031

Report ID: 1024886 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Molecular Influenza Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
        1.2.3 Nucleic Acid Sequence Based Amplification (NASBA) Tests
        1.2.4 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
        1.2.5 Simple Amplification-based Assays (SAMBA)
    1.3 Market by Application
        1.3.1 Global Molecular Influenza Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 POCT
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Molecular Influenza Diagnostic Market Perspective (2016-2027)
    2.2 Molecular Influenza Diagnostic Growth Trends by Regions
        2.2.1 Molecular Influenza Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Molecular Influenza Diagnostic Historic Market Share by Regions (2016-2021)
        2.2.3 Molecular Influenza Diagnostic Forecasted Market Size by Regions (2022-2027)
    2.3 Molecular Influenza Diagnostic Industry Dynamic
        2.3.1 Molecular Influenza Diagnostic Market Trends
        2.3.2 Molecular Influenza Diagnostic Market Drivers
        2.3.3 Molecular Influenza Diagnostic Market Challenges
        2.3.4 Molecular Influenza Diagnostic Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Molecular Influenza Diagnostic Players by Revenue
        3.1.1 Global Top Molecular Influenza Diagnostic Players by Revenue (2016-2021)
        3.1.2 Global Molecular Influenza Diagnostic Revenue Market Share by Players (2016-2021)
    3.2 Global Molecular Influenza Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Molecular Influenza Diagnostic Revenue
    3.4 Global Molecular Influenza Diagnostic Market Concentration Ratio
        3.4.1 Global Molecular Influenza Diagnostic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Molecular Influenza Diagnostic Revenue in 2020
    3.5 Molecular Influenza Diagnostic Key Players Head office and Area Served
    3.6 Key Players Molecular Influenza Diagnostic Product Solution and Service
    3.7 Date of Enter into Molecular Influenza Diagnostic Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Influenza Diagnostic Breakdown Data by Type
    4.1 Global Molecular Influenza Diagnostic Historic Market Size by Type (2016-2021)
    4.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2022-2027)

5 Molecular Influenza Diagnostic Breakdown Data by Application
    5.1 Global Molecular Influenza Diagnostic Historic Market Size by Application (2016-2021)
    5.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Molecular Influenza Diagnostic Market Size (2016-2027)
    6.2 North America Molecular Influenza Diagnostic Market Size by Type
        6.2.1 North America Molecular Influenza Diagnostic Market Size by Type (2016-2021)
        6.2.2 North America Molecular Influenza Diagnostic Market Size by Type (2022-2027)
        6.2.3 North America Molecular Influenza Diagnostic Market Size by Type (2016-2027)
    6.3 North America Molecular Influenza Diagnostic Market Size by Application
        6.3.1 North America Molecular Influenza Diagnostic Market Size by Application (2016-2021)
        6.3.2 North America Molecular Influenza Diagnostic Market Size by Application (2022-2027)
        6.3.3 North America Molecular Influenza Diagnostic Market Size by Application (2016-2027)
    6.4 North America Molecular Influenza Diagnostic Market Size by Country
        6.4.1 North America Molecular Influenza Diagnostic Market Size by Country (2016-2021)
        6.4.2 North America Molecular Influenza Diagnostic Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Molecular Influenza Diagnostic Market Size (2016-2027)
    7.2 Europe Molecular Influenza Diagnostic Market Size by Type
        7.2.1 Europe Molecular Influenza Diagnostic Market Size by Type (2016-2021)
        7.2.2 Europe Molecular Influenza Diagnostic Market Size by Type (2022-2027)
        7.2.3 Europe Molecular Influenza Diagnostic Market Size by Type (2016-2027)
    7.3 Europe Molecular Influenza Diagnostic Market Size by Application
        7.3.1 Europe Molecular Influenza Diagnostic Market Size by Application (2016-2021)
        7.3.2 Europe Molecular Influenza Diagnostic Market Size by Application (2022-2027)
        7.3.3 Europe Molecular Influenza Diagnostic Market Size by Application (2016-2027)
    7.4 Europe Molecular Influenza Diagnostic Market Size by Country
        7.4.1 Europe Molecular Influenza Diagnostic Market Size by Country (2016-2021)
        7.4.2 Europe Molecular Influenza Diagnostic Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Molecular Influenza Diagnostic Market Size (2016-2027)
    8.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type
        8.2.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2016-2027)
    8.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application
        8.3.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2016-2027)
    8.4 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region
        8.4.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Molecular Influenza Diagnostic Market Size (2016-2027)
    9.2 Latin America Molecular Influenza Diagnostic Market Size by Type
        9.2.1 Latin America Molecular Influenza Diagnostic Market Size by Type (2016-2021)
        9.2.2 Latin America Molecular Influenza Diagnostic Market Size by Type (2022-2027)
        9.2.3 Latin America Molecular Influenza Diagnostic Market Size by Type (2016-2027)
    9.3 Latin America Molecular Influenza Diagnostic Market Size by Application
        9.3.1 Latin America Molecular Influenza Diagnostic Market Size by Application (2016-2021)
        9.3.2 Latin America Molecular Influenza Diagnostic Market Size by Application (2022-2027)
        9.3.3 Latin America Molecular Influenza Diagnostic Market Size by Application (2016-2027)
    9.4 Latin America Molecular Influenza Diagnostic Market Size by Country
        9.4.1 Latin America Molecular Influenza Diagnostic Market Size by Country (2016-2021)
        9.4.2 Latin America Molecular Influenza Diagnostic Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Molecular Influenza Diagnostic Market Size (2016-2027)
    10.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type
        10.2.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2016-2027)
    10.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application
        10.3.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2016-2027)
    10.4 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country
        10.4.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 BD
        11.1.1 BD Company Details
        11.1.2 BD Business Overview
        11.1.3 BD Molecular Influenza Diagnostic Introduction
        11.1.4 BD Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.1.5 BD Recent Development
    11.2 Abbott (Include Alere)
        11.2.1 Abbott (Include Alere) Company Details
        11.2.2 Abbott (Include Alere) Business Overview
        11.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Introduction
        11.2.4 Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.2.5 Abbott (Include Alere) Recent Development
    11.3 Roche
        11.3.1 Roche Company Details
        11.3.2 Roche Business Overview
        11.3.3 Roche Molecular Influenza Diagnostic Introduction
        11.3.4 Roche Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.3.5 Roche Recent Development
    11.4 SIEMENS
        11.4.1 SIEMENS Company Details
        11.4.2 SIEMENS Business Overview
        11.4.3 SIEMENS Molecular Influenza Diagnostic Introduction
        11.4.4 SIEMENS Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.4.5 SIEMENS Recent Development
    11.5 Analytik Jena
        11.5.1 Analytik Jena Company Details
        11.5.2 Analytik Jena Business Overview
        11.5.3 Analytik Jena Molecular Influenza Diagnostic Introduction
        11.5.4 Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.5.5 Analytik Jena Recent Development
    11.6 Quidel
        11.6.1 Quidel Company Details
        11.6.2 Quidel Business Overview
        11.6.3 Quidel Molecular Influenza Diagnostic Introduction
        11.6.4 Quidel Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.6.5 Quidel Recent Development
    11.7 Thermo Fisher
        11.7.1 Thermo Fisher Company Details
        11.7.2 Thermo Fisher Business Overview
        11.7.3 Thermo Fisher Molecular Influenza Diagnostic Introduction
        11.7.4 Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.7.5 Thermo Fisher Recent Development
    11.8 Meridian Bioscience
        11.8.1 Meridian Bioscience Company Details
        11.8.2 Meridian Bioscience Business Overview
        11.8.3 Meridian Bioscience Molecular Influenza Diagnostic Introduction
        11.8.4 Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.8.5 Meridian Bioscience Recent Development
    11.9 BioMerieux
        11.9.1 BioMerieux Company Details
        11.9.2 BioMerieux Business Overview
        11.9.3 BioMerieux Molecular Influenza Diagnostic Introduction
        11.9.4 BioMerieux Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.9.5 BioMerieux Recent Development
    11.10 Sekisui Diagnostics
        11.10.1 Sekisui Diagnostics Company Details
        11.10.2 Sekisui Diagnostics Business Overview
        11.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Introduction
        11.10.4 Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.10.5 Sekisui Diagnostics Recent Development
    11.11 Response Biomedical
        11.11.1 Response Biomedical Company Details
        11.11.2 Response Biomedical Business Overview
        11.11.3 Response Biomedical Molecular Influenza Diagnostic Introduction
        11.11.4 Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.11.5 Response Biomedical Recent Development
    11.12 SA Scientific
        11.12.1 SA Scientific Company Details
        11.12.2 SA Scientific Business Overview
        11.12.3 SA Scientific Molecular Influenza Diagnostic Introduction
        11.12.4 SA Scientific Revenue in Molecular Influenza Diagnostic Business (2016-2021)
        11.12.5 SA Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Molecular Influenza Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    Table 3. Key Players of Nucleic Acid Sequence Based Amplification (NASBA) Tests
    Table 4. Key Players of Loop-mediated Isothermal Amplification-Based Assays (LAMP)
    Table 5. Key Players of Simple Amplification-based Assays (SAMBA)
    Table 6. Global Molecular Influenza Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Molecular Influenza Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Molecular Influenza Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Molecular Influenza Diagnostic Market Share by Regions (2016-2021)
    Table 10. Global Molecular Influenza Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Molecular Influenza Diagnostic Market Share by Regions (2022-2027)
    Table 12. Molecular Influenza Diagnostic Market Trends
    Table 13. Molecular Influenza Diagnostic Market Drivers
    Table 14. Molecular Influenza Diagnostic Market Challenges
    Table 15. Molecular Influenza Diagnostic Market Restraints
    Table 16. Global Molecular Influenza Diagnostic Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Molecular Influenza Diagnostic Market Share by Players (2016-2021)
    Table 18. Global Top Molecular Influenza Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Influenza Diagnostic as of 2020)
    Table 19. Ranking of Global Top Molecular Influenza Diagnostic Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Molecular Influenza Diagnostic Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Molecular Influenza Diagnostic Product Solution and Service
    Table 23. Date of Enter into Molecular Influenza Diagnostic Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2016-2021)
    Table 27. Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Molecular Influenza Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Molecular Influenza Diagnostic Revenue Market Share by Application (2016-2021)
    Table 31. Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Molecular Influenza Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. BD Company Details
    Table 64. BD Business Overview
    Table 65. BD Molecular Influenza Diagnostic Product
    Table 66. BD Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 67. BD Recent Development
    Table 68. Abbott (Include Alere) Company Details
    Table 69. Abbott (Include Alere) Business Overview
    Table 70. Abbott (Include Alere) Molecular Influenza Diagnostic Product
    Table 71. Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 72. Abbott (Include Alere) Recent Development
    Table 73. Roche Company Details
    Table 74. Roche Business Overview
    Table 75. Roche Molecular Influenza Diagnostic Product
    Table 76. Roche Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 77. Roche Recent Development
    Table 78. SIEMENS Company Details
    Table 79. SIEMENS Business Overview
    Table 80. SIEMENS Molecular Influenza Diagnostic Product
    Table 81. SIEMENS Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 82. SIEMENS Recent Development
    Table 83. Analytik Jena Company Details
    Table 84. Analytik Jena Business Overview
    Table 85. Analytik Jena Molecular Influenza Diagnostic Product
    Table 86. Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 87. Analytik Jena Recent Development
    Table 88. Quidel Company Details
    Table 89. Quidel Business Overview
    Table 90. Quidel Molecular Influenza Diagnostic Product
    Table 91. Quidel Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 92. Quidel Recent Development
    Table 93. Thermo Fisher Company Details
    Table 94. Thermo Fisher Business Overview
    Table 95. Thermo Fisher Molecular Influenza Diagnostic Product
    Table 96. Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 97. Thermo Fisher Recent Development
    Table 98. Meridian Bioscience Company Details
    Table 99. Meridian Bioscience Business Overview
    Table 100. Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 101. Meridian Bioscience Recent Development
    Table 102. BioMerieux Company Details
    Table 103. BioMerieux Business Overview
    Table 104. BioMerieux Molecular Influenza Diagnostic Product
    Table 105. BioMerieux Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 106. BioMerieux Recent Development
    Table 107. Sekisui Diagnostics Company Details
    Table 108. Sekisui Diagnostics Business Overview
    Table 109. Sekisui Diagnostics Molecular Influenza Diagnostic Product
    Table 110. Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 111. Sekisui Diagnostics Recent Development
    Table 112. Response Biomedical Company Details
    Table 113. Response Biomedical Business Overview
    Table 114. Response Biomedical Molecular Influenza Diagnostic Product
    Table 115. Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 116. Response Biomedical Recent Development
    Table 117. SA Scientific Company Details
    Table 118. SA Scientific Business Overview
    Table 119. SA Scientific Molecular Influenza Diagnostic Product
    Table 120. SA Scientific Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
    Table 121. SA Scientific Recent Development
    Table 122. Research Programs/Design for This Report
    Table 123. Key Data Information from Secondary Sources
    Table 124. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Molecular Influenza Diagnostic Market Share by Type: 2020 VS 2027
    Figure 2. Reverse Transcription Polymerase Chain Reaction (RT-PCR) Features
    Figure 3. Nucleic Acid Sequence Based Amplification (NASBA) Tests Features
    Figure 4. Loop-mediated Isothermal Amplification-Based Assays (LAMP) Features
    Figure 5. Simple Amplification-based Assays (SAMBA) Features
    Figure 6. Global Molecular Influenza Diagnostic Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. POCT Case Studies
    Figure 9. Others Case Studies
    Figure 10. Molecular Influenza Diagnostic Report Years Considered
    Figure 11. Global Molecular Influenza Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Molecular Influenza Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Molecular Influenza Diagnostic Market Share by Regions: 2020 VS 2027
    Figure 14. Global Molecular Influenza Diagnostic Market Share by Regions (2022-2027)
    Figure 15. Global Molecular Influenza Diagnostic Market Share by Players in 2020
    Figure 16. Global Top Molecular Influenza Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Influenza Diagnostic as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Molecular Influenza Diagnostic Revenue in 2020
    Figure 18. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2016-2021)
    Figure 19. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2022-2027)
    Figure 20. North America Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Molecular Influenza Diagnostic Market Share by Type (2016-2027)
    Figure 22. North America Molecular Influenza Diagnostic Market Share by Application (2016-2027)
    Figure 23. North America Molecular Influenza Diagnostic Market Share by Country (2016-2027)
    Figure 24. United States Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Molecular Influenza Diagnostic Market Share by Type (2016-2027)
    Figure 28. Europe Molecular Influenza Diagnostic Market Share by Application (2016-2027)
    Figure 29. Europe Molecular Influenza Diagnostic Market Share by Country (2016-2027)
    Figure 30. Germany Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Molecular Influenza Diagnostic Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Molecular Influenza Diagnostic Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Molecular Influenza Diagnostic Market Share by Region (2016-2027)
    Figure 40. China Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Molecular Influenza Diagnostic Market Share by Type (2016-2027)
    Figure 48. Latin America Molecular Influenza Diagnostic Market Share by Application (2016-2027)
    Figure 49. Latin America Molecular Influenza Diagnostic Market Share by Country (2016-2027)
    Figure 50. Mexico Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Molecular Influenza Diagnostic Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Molecular Influenza Diagnostic Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Molecular Influenza Diagnostic Market Share by Country (2016-2027)
    Figure 56. Turkey Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. BD Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 60. Abbott (Include Alere) Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 61. Roche Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 62. SIEMENS Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 63. Analytik Jena Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 64. Quidel Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 65. Thermo Fisher Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 66. Meridian Bioscience Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 67. BioMerieux Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 68. Sekisui Diagnostics Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 69. Response Biomedical Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 70. SA Scientific Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Frequently Asked Questions
Molecular Influenza Diagnostic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Molecular Influenza Diagnostic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Molecular Influenza Diagnostic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports